Scott L. Young
Impact in
- Toxicology top 10%
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 3
- Cytokine Signaling Pathways and Interactions 1
- Vascular Tumors and Angiosarcomas 1
- Cancer-related Molecular Pathways 1
-
- Angiogenesis and VEGF in Cancer 2
- Co-authors
- David J. Chaplin (2 shared papers)Mitchell D. Schnall (1 shared paper)Ross Zimmer (1 shared paper)Daniel G. Haller (1 shared paper)James Stevenson (1 shared paper)Weijing Sun (1 shared paper)William P. Petros (1 shared paper)Peter J. O’Dwyer (1 shared paper)
- Journals
- Investigative Ophthalmology & Visual Science (2 papers)Expert Opinion on Investigational Drugs (1 paper)Journal of Clinical Oncology (1 paper)Journal of Allergy and Clinical Immunology (1 paper)Cancer Research (1 paper)
- Partner nations
- United States
In The Last Decade
Scott L. Young
5 papers receiving 415 citations
Peers
Comparison fields: 5 of 60
- Toxicology 19
- Cancer Research 74
- Oncology 109
- Organic Chemistry 110
- Radiology, Nuclear Medicine and Imaging 79
Countries citing papers authored by Scott L. Young
This map shows the geographic impact of Scott L. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott L. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott L. Young more than expected).
Fields of papers citing papers by Scott L. Young
This network shows the impact of papers produced by Scott L. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott L. Young. The network helps show where Scott L. Young may publish in the future.
Co-authors
The 21 scholars most cited alongside Scott L. Young, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 251 | |
| 2 | 2004 | 163 | |
| 3 | Lack of clastogenicity of combretastatin A-4 (CA4) - microtubule destabilizing agent, in human peripheral blood lymphocytes in vitro | 2005 | 5 |
| 4 | A Randomized, Comparator-Controlled Phase 2 Clinical Trial of ADX-102 Ophthalmic Solution in Noninfectious Anterior Uveitis | 2017 | 4 |
| 5 | The Aldehyde Trap NS2 Mitigates Dense Haze in a Rabbit Model of Photorefractive Keratectomy | 2015 | 1 |
| 6 | 2015 | 1 |
About Scott L. Young
Scott L. Young is a scholar working on Oncology, Molecular Biology, Physiology, Cancer Research and Pharmacology, having authored 6 papers that have together received 425 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (2 papers), Microtubule and mitosis dynamics (1 paper), Cancer Genomics and Diagnostics (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Vascular Tumors and Angiosarcomas (1 paper), Cancer-related Molecular Pathways (1 paper) and MRI in cancer diagnosis (1 paper). The work is most often cited by research in Toxicology (19 citations), Cancer Research (74 citations), Oncology (109 citations), Organic Chemistry (110 citations) and Radiology, Nuclear Medicine and Imaging (79 citations). Scott L. Young has collaborated with scholars based in United States. Frequent co-authors include David J. Chaplin, Mitchell D. Schnall, Ross Zimmer, Daniel G. Haller, James Stevenson, Weijing Sun, William P. Petros, Peter J. O’Dwyer, Bruce J. Giantonio and David J. Vaughn. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Expert Opinion on Investigational Drugs, Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.